Aurinia Pharmaceuticals (AUPH) Profit After Tax (2019 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Profit After Tax came in at $34.1 million in Q1 2026, up 45.96% YoY from $23.3 million in Q1 2025, and down 83.84% on a QoQ basis from $210.8 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Profit After Tax (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 8 years of Profit After Tax data on file, last reported at $34.1 million in Q1 2026.
- Quarterly Profit After Tax rose 45.96% year-over-year to $34.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $297.9 million (up 647.73% YoY) and the FY2025 annual result came in at $287.2 million, up 4822.88% from the prior year.
- Profit After Tax fell to $34.1 million in Q1 2026, from $210.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $210.8 million in Q4 2025 to a low of -$37.6 million in Q1 2022.
- A 5-year average of $8.3 million and a median of -$9.0 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax plunged 49.59% — and 2025, when it surged 14651.15%.
- Tracing AUPH's Profit After Tax over 5 years: stood at -$26.0 million in 2022, then retreated by 3.18% to -$26.9 million in 2023, then surged by 105.32% to $1.4 million in 2024, then surged by 14651.15% to $210.8 million in 2025, then plunged by 83.84% to $34.1 million in 2026.
- The last three Profit After Tax figures came in at $34.1 million (Q1 2026), $210.8 million (Q4 2025), and $31.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.41 Mn |
| Mar 31, 2026 | 34.07 Mn |
| Dec 31, 2025 | 210.79 Mn |
| Sep 30, 2025 | 31.55 Mn |
| Jun 30, 2025 | 21.51 Mn |
| Mar 31, 2025 | 23.34 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 14.35 Mn |
| Jun 30, 2024 | 722,000.00 |
| Mar 31, 2024 | -10.75 Mn |
| Dec 31, 2023 | -26.88 Mn |
| Sep 30, 2023 | -13.45 Mn |
| Jun 30, 2023 | -11.49 Mn |
| Mar 31, 2023 | -26.21 Mn |
| Dec 31, 2022 | -26.05 Mn |
| Sep 30, 2022 | -8.99 Mn |
| Jun 30, 2022 | -35.52 Mn |
| Mar 31, 2022 | -37.63 Mn |
| Dec 31, 2021 | -33.32 Mn |
| Sep 30, 2021 | -50.26 Mn |